Search
Search
ASRS: 2024
Chirag Jhaveri, MD
Show Description +
Dr. Jhaveri discusses data from the ALTIMETER trial of faricimab (Vabysmo, Genentech/Roche) that explored biomarkers of Ang-2 inhibition in patients with DME.
Posted: 8/01/2024
Chirag Jhaveri, MD
Dr. Jhaveri discusses data from the ALTIMETER trial of faricimab (Vabysmo, Genentech/Roche) that explored biomarkers of Ang-2 inhibition in patients with DME.
Posted: 8/01/2024
Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of ASRS: 2024.
_1722955835.png?auto=compress,format&w=180)
_1722955753.png?auto=compress,format&w=180)
_1722955632.png?auto=compress,format&w=180)
_1722955835.png?auto=compress,format&w=504)
_1722955753.png?auto=compress,format&w=504)
_1722955632.png?auto=compress,format&w=504)
Please log in to leave a comment.